Cat. No. | Product name | CAS No. |
DC11967 |
PF-06649298
A potent, selective inhibitor of the Na+/citrate transporter NaCT (SLC13A5) that shows inhibition of citrate uptake in the HEKNaCT cells with IC50 of 0.41 uM. |
1854061-16-7 |
DC22754 |
SKA-111
A potent, selective intermediate-conductance KCa3.1 positive-gating modulator with EC50 of 111 nM. |
1369170-24-0 |
DC23551 |
PF-05388169
A potent, selective IRAK4 inhibitor with IC50 of 0.094 nM, >500-fold selectivity over IRAK1 (IC50=65 nM). |
1604034-78-7 |
DC23550 |
PF-05387252
A potent, selective IRAK4 inhibitor with IC50 of 1.3 nM, 200-fold selectivity over IRAK1 (IC50=290 nM). |
1604034-71-0 |
DC11507 |
CLP257
Featured
CLP257 (CLP-257) is a potent, selective K+-Cl- cotransporter KCC2 activator with EC50 of 616 nM; displays selectivity for KCC2 over other KCC family members, NKCC1 and GABAA receptors, and a panel of 55 other receptors; restores impaired Cl(-) transport i |
1181081-71-9 |
DC22677 |
(±)-U-50488 hydrochloride
A potent, selective kappa-opioid receptor agonist with no μ-opioid antagonist effects. |
67197-96-0 |
DC11503 |
KDOAM-25
Featured
A potent, selective KDM5 sub-family(JARID1) inhibitor with biochemical IC50 of 71/19/69/69 nM for KDM5A/B/C/D, respectively. |
2230731-99-2 |
DC11650 |
Ro5-4864
Featured
A potent, selective ligand for the mitochondrial translocator protein 18kDa (TSPO/PBR). |
14439-61-3 |
DC22858 |
LIMK-IN-14
A potent, selective LIMK inhibitor with IC50 of 0.9 nM and 0.5 nM and 1.2 nM for LIMK1 and LIMK2, respectively. |
1116570-97-8 |
DC22859 |
LIMK-IN-22j
A potent, selective LIMK inhibitor with IC50 of 3.2 nM and 1.2 nM for LIMK1 and LIMK2, respectively. |
1116571-01-7 |
DC24026 |
LPA2-IN-1
A potent, selective LPA2 (EDG4) antagonist with IC50 of 17 nM. |
1017606-66-4 |
DC22364 |
DG051
A potent, selective LTA4H (Leukotriene A4 hydrolase) inhibitor (IC50/Kd=47/25 nM) of leukotriene B4 biosynthesis. |
929915-58-2 |
DC20722 |
AZD-1979
A potent, selective melanin concentrating hormone receptor 1 (MCH-R1) antagonist with binding Ki of 12.2 nM. |
1254035-84-1 |
DC26072 |
BMS 819881
A potent, selective melanin concentrating hormone receptor 1 (MCHR1) inhibitor with Ki of 10.4 nM. |
1197420-05-5 |
DC22710 |
LY3020371 hydrochloride
A potent, selective metabotropic glutamate 2/3 receptor (mGlu2/3) antagonist with Ki of 5.3 and 2.5 nM, respectively. |
1377615-44-5 |
DC22921 |
AMN 082
A potent, selective mGluR7 allosteric agonist that inhibits forskolin-stimulated cAMP accumulation in mGluR7b CHO cells with EC50 of 64±32 nM. |
83027-13-8 |
DC11630 |
ND-378
A potent, selective MMP-2 inhibitor with Ki of 230 nM. |
1807453-72-0 |
DC21573 |
Ro 5212773
Featured
EPPTB is a selective antagonist of the trace amine-associated receptor 1 (TAAR1). |
1110781-88-8 |
DC24163 |
XEN-907
A potent, selective NaV1.7 blocker with IC50 of 3 nM. |
912656-34-9 |
DC23603 |
Traxoprodil mesylate
Featured
A potent, selective N-methyl-D-aspartate (NMDA) antagonist with selectivity for the NR2B subunit. |
188591-67-5 |
DC20771 |
Faldaprevir
A potent, selective noncovalent competitive inhibitor of HCV NS3/4A protease with Ki of 2.6 and 2.0 nM for GT1a and 1b NS3-NS4A protease, respectively. |
801283-95-4 |
DC22726 |
SB 290157
A potent, selective nonpeptide antagonist of anaphylatoxin C3a receptor (C3aR) with IC50 of 200 nM. |
259218-28-5 |
DC22672 |
SB-612111 hydrochloride
A potent, selective opiate receptor-like orphan receptor (ORL-1, NOP) antagonist with Ki of 0.33 nM. |
371980-94-8 |
DC22947 |
RN-9893 hydrochloride
A potent, selective orally-bioavailable TRPV4 antagonist with IC50 of 320, 420 and 660 nM for mouse, human and rat TRPV4 channels, respectively. |
2109450-40-8 |
DC22951 |
RN-9893
A potent, selective orally-bioavailable TRPV4 antagonist with IC50 of 320, 420 and 660 nM for mouse, human and rat TRPV4 channels, respectively. |
1803003-68-0 |
DC24064 |
SB-408124 hydrochloride
Featured
A potent, selective OX1 receptor antagonist with Ki of 57 nM (whole cell assay), and 27 nM (cell membrane-based SPA assay). |
1431697-90-3 |
DC11849 |
DSM421
A potent, selective P. falciparum dihydroorotate dehydrogenase (PfDHODH) with IC50 of 53 nM. |
1281861-06-0 |
DC23213 |
SCIO-469
A potent, selective p38α MAPK inhibitor with IC50 of 9 nM. |
309913-83-5 |
DC22577 |
Revizinone
A potent, selective PDE3 inhibitor with IC50 of 36 nM, displays >20,000-fold selectivity over PDE1.. |
133718-29-3 |
DC22963 |
Org-9935
A potent, selective PDE3 inhibitor with IC50 of 50 nM. |
129425-83-8 |
DC22942 |
BeKm-1
A potent, selective peptide inhibitor of hERG channel with IC50 of 3.3 nM for hERG1 channels. |
524962-01-4 |
DC22767 |
UK-500001
A potent, selective phosphodiesterase 4 (PDE4) inhibitor with IC50 of 26.1, 22.8, 21 and 0.28 nM for PDE4A4, PDE4B2, PDE4C2 and PDE4D3, respectively.. |
582332-31-8 |
DC11635 |
Poloxin-2
A potent, selective PLK1 PBD inhibitor with IC50 of 1.36 uM. |
1807690-39-6 |
DC22535 |
CGP-25454A
A potent, selective presynaptic dopamine autoreceptor antagonist. |
104391-26-6 |
DC21587 |
RR 601
A potent, selective protein tyrosine phosphatase DUSP5, PTP1B and SHP-2 inhibitor with IC50 of 36 uM, 2.1 and 1.1 uM respectively, 8-fold selectivity for PTP1B versus DUSP5. |
1970119-63-1 |
DC26105 |
AGN-195183
A potent, selective RARα agonist. |
367273-07-2 |
DC22996 |
LE-540
A potent, selective RARβ antagonist that inhibits RA-induced transcriptional activation of RARβ, but not RARα, RARγ or RXRα on a variety of RA response elements. |
188645-44-5 |
DC22547 |
RIPK2-IN-2
A potent, selective receptor interacting protein-2 (RIP2) kinase inhibitor.. |
1581270-11-2 |
DC11942 |
VU591
A potent, selective renal outer medullary potassium channel (ROMK, Kir1.1) inhibitor with IC50 of 0.24 uM in T1+ flux assays. |
1222810-74-3 |
DC22701 |
SEW2871
A potent, selective S1P1 receptor full agonist with EC50 of 13.8 nM, with no activites at the S1P2-5 receptors. |
256414-75-2 |
DC11560 |
SPM-242
A potent, selective S1P3 antagonist with Ki of 0.25 nM. |
|
DC11561 |
SPM-242 racemate
A potent, selective S1P3 antagonist with Ki of 0.25 nM. |
749263-43-2 |
DC22702 |
PD144418
A potent, selective sigma 1 ligand with Ki of 0.08 nM, >3000-fold selectivity over sigma 2 (Ki=1377 nM). |
154130-99-1 |
DC22663 |
CB-64D
A potent, selective sigma-2 receptor agonist with Ki of 16.5 nM, 200-fold selectivity over sigma 1 (Ki=3063 nM). |
157752-20-0 |
DC22703 |
CM 764
A potent, selective sigma-2 receptor agonist with Ki of 3.5 nM, 25-fold selectivity over sigma-1 receptors (Ki=86.6 nM). |
1350296-29-5 |
DC21700 |
Stafib-1
Featured
A potent, selective small molecule inhibitor of transcription factor STAT5b with Ki of 44 nM, >50-fold selectivity over STAT5a.. |
1688703-26-5 |
DC23946 |
PAP-1
Featured
PAP-1 is a selective inhibitor of Kv1.3, voltage-gated K+ channel. PAP-1 (EC50=2 nM) potently inhibits human T effector memory cell proliferation and delayed hypersensitivity. IC50 value: 2 nM (EC50) [1]in vitro: blocks Kv1.3 in a use-dependent manner, with a Hill coefficient of 2 and an EC50 of 2 nM, by preferentially binding to the C-type inactivated state of the channel. PAP-1 is 23-fold selective over Kv1.5, 33- to 125-fold selective over other Kv1-family channels, and 500- to 7500-fold selective over Kv2.1, Kv3.1, Kv3.2, Kv4.2, HERG, calcium-activated K+ channels, Na+,Ca2+, and Cl- channels [1]. The blockade of Kv1.3 results in membrane depolarization and inhibition of TEM proliferation and function. In this study, the in vitro effects of PAP-1 on T cells and the in vivo toxicity and pharmacokinetics (PK) were examined in rhesus macaques (RM) with the ultimate aim of utilizing PAP-1 to define the role of TEMs in RM infected with simian immunodeficiency virus (SIV). Electrophysiologic studies on T cells in RM revealed a Kv1.3 expression pattern similar to that in human T cells. Thus, PAP-1 effectively suppressed TEM proliferation in RM [2].in vivo: PAP-1 does not exhibit cytotoxic or phototoxic effects, is negative in the Ames test, and affects cytochrome P450-dependent enzymes only at micromolar concentrations. PAP-1 potently inhibits the proliferation of human TEM cells and suppresses delayed type hypersensitivity, a TEM cell-mediated reaction, in rats [1]. When administered intravenously, PAP-1 showed a half-life of 6.4 hrs; the volume of distribution suggested extensive distribution into extravascular compartments. When orally administered, PAP-1 was efficiently absorbed. Plasma concentrations in RM undergoing a 30-day, chronic dosing study indicated that PAP-1 levels suppressive to TEMs in vitro can be achieved and maintained in vivo at a non-toxic dose [2]. |
870653-45-5 |
DC23927 |
MIM1
A potent, selective small molecule Mcl-1 inhibitor that selectively targets the BH3-binding groove of Mcl-1. |
509102-00-5 |
DC23623 |
PF-06761281
Featured
A potent, selective sodium-coupled citrate transporter (NaCT or SLC13A5) with IC50 of 0.51 uM, >20-fold selectivity over NaDC1 and NaDC3. |
1854061-19-0 |
DC26089 |
MNS
A potent, selective Src and Syk kinase inhibitor with IC50 of 29.3 uM and 2.5 uM, respectively. |
1485-00-3 |
DC20557 |
STAT3 inhibitor C188
A potent, selective STAT3 inhibitor that blocks STAT3 binding to its phosphopeptide ligand (IC50=20 uM) and inhibits IL-6-mediated phosphorylation of STAT3. |
823828-18-8 |
DC20375 |
Erasin
A potent, selective STAT3 inhibitor with IC50 of 9.7 uM, inhibits tyrosine phosphorylation of STAT3 with selectivity over STAT5 and STAT1 in cell-based assays. |
|
DC20824 |
BP-5-087
A potent, selective STAT3 SH2 domain inhibitor (EC50=5.6 uM) that reduces STAT3 phosphorylation and nuclear transactivation. |
1803281-30-2 |
DC21580 |
RO 5166017
A potent, selective TAAR1 agonist with Ki of 1.9, 2.7, 31 and 24 nM for mouse, rat, cynomolgus monkey and human TAAR1 stably expressed in HEK293 cells. |
1048346-74-2 |
DC20593 |
5Z-7-Oxozeaenol
A potent, selective TAK1 inhibitor with IC50 of 8 nM, displays >33-fold and >62-fold selectivity over MEKK1 and MEKK4 respectively. |
253863-19-3 |
DC22578 |
TPO-Agonist-1
A potent, selective thrombopoietin (TPO) receptor agonist.. |
1033040-23-1 |
DC23548 |
TLR9 inhibitor 18
A potent, selective TLR9 antagonist with IC50 of 13 nM (human TLR9), displays 75-fold selectivity over TLR7 and no activity against TLR8 (IC50>10 uM). |
1351978-48-7 |
DC20878 |
CDK7 and 9 inhibitor 14
A potent, selective transcriptional CDK inhibitor with Ki of 2.3 and 0.38 nM for CDK7 and CDK9, respectively. |
851439-14-0 |
DC22786 |
CB34
A potent, selective translocator protein 18 kDa (TSPO/PBR) agonist with IC50 of 2.59 and 1.03 nM in competing with [3H]-PK11195 for binding to membrane preparations from rat cerebral cortex and ovary, respectively. |
193979-75-8 |
DC21220 |
Larixyl acetate
A potent, selective TRPC6 channel inhibitor with IC50 of 0.1-0.6 uM, 12- and 5-fold selectivity over related TRPC3 and TRPC7. |
4608-49-5 |
DC21820 |
WS-12
A potent, selective TRPM8 agonist with EC50 of 12 uM, a cooling agent. |
68489-09-8 |
DC24043 |
USP8-IN-22e
Featured
A potent, selective ubiquitin-specific protease USP8 inhibitor with IC50 of 0.28 uM. |
924296-19-5 |
DC24042 |
USP8-IN-22c
A potent, selective ubiquitin-specific protease USP8 inhibitor with IC50 of 0.56 uM. |
924296-17-3 |
DC24041 |
USP8-IN-22d
A potent, selective ubiquitin-specific protease USP8 inhibitor with IC50 of 0.85 uM. |
924296-18-4 |
DC22696 |
BRL 44408
Featured
A potent, selective α2A-adrenoceptor antagonist with Ki of 1.7 nM, 80-fold selectivity over α2B-adrenergic receptors. |
118343-19-4 |
DC22695 |
BRL 44408 maleate
A potent, selective α2A-adrenoceptor antagonist with Ki of 1.7 nM, 80-fold selectivity over α2B-adrenergic receptors. |
681806-46-2 |
DC22694 |
ARC 239 dihydrochloride
A potent, selective α2B adrenoceptor antagonist with pKd of 8.8, 200-fold selectivity over α2A, and α2D receptors. |
55974-42-0 |
DC22536 |
CFMTI
Featured
A potent, selective, allosteric and oral mGluR1 antaognist with IC50 of 2.6 and 2.3 nM for human and rat mGluR1, respectively. |
864864-17-5 |
DC22753 |
NS13001
Featured
A potent, selective, allosteric and orally acitve positive modulator of small-conductance calcium-activated K+ channel KCa2.2 and KCa2.3 with EC50 of 1.6 and 0.14 uM, respectively. |
1063331-94-1 |
DC11745 |
BMS-22
A potent, selective, allosteric CCR2 antagonist with binding IC50 of 5.1 nM. |
445479-97-0 |
DC11744 |
CCR2-RA-[R]
A potent, selective, allosteric CCR2 antagonist with IC50 of 103 nM.. |
512177-83-2 |
DC21316 |
ML400
A potent, selective, allosteric LMPTP inhibitor with IC50 of 1.68 uM, displays good selective against other phosphatases. |
1908414-42-5 |
DC22916 |
JNJ-10397049
A potent, selective, and bioavailable OX2 receptor antagonist with Kb of 4.5 nM. |
708275-58-5 |
DC23971 |
LY450108
A potent, selective, and centrally active positive allosteric modulator of AMPAR-mediated neurotransmission, which increase ion channel flux in the presence of agonist by suppressing desensitization and/or deactivation of the receptors.. |
376594-67-1 |
DC24030 |
LY451395
Featured
A potent, selective, and centrally active positive allosteric modulator of AMPAR-mediated neurotransmission, which increase ion channel flux in the presence of agonist by suppressing desensitization and/or deactivation of the receptors.. |
375345-95-2 |
DC23963 |
QL-47
A potent, selective, and irreversible BTK inhibitor with IC50 of 7 nM. |
1469988-75-7 |
DC21545 |
PXS-4681A
A potent, selective, and irreversible inhibitor of SSAO/VAP-1 (AOC3) with Ki of 37 nM, IC50 of <10 nM. |
1478364-87-2 |
DC11850 |
MK-7145
A potent, selective, and oral renal outer medullary potassium channel (ROMK) inhibitor with IC50 of 68 nM. |
1255204-84-2 |
DC11727 |
RO-2468
A potent, selective, and orally active p53-MDM2 antagonist with IC50 of 6 nM. |
1360821-21-1 |
DC11728 |
RO-5353
A potent, selective, and orally active p53-MDM2 antagonist with IC50 of 7 nM. |
1360821-61-9 |
DC21254 |
LY-517717
A potent, selective, and orally bioavailable factor Xa (FXa) inhibitor for prevention and treatment of thromboembolic diseases.. |
313489-71-3 |
DC21487 |
PF-05190457
Featured
A potent, selective, and orally bioavailable ghrelin receptor (GHSR) inverse agonist with binding pKi of 8.36. |
1334782-79-4 |
DC23541 |
IRAK4-IN-16
A potent, selective, and orally bioavailable inhibitor of interleukin-1 receptor-associate kinase-4 (IRAK4) with IC50 of 2.8 nM, 217- and 892-fold selectivity over IRAK-1 and TAK1, respectively. |
509093-72-5 |
DC23949 |
CX-6258 hydrochloride hydrate
A potent, selective, and orally efficacious pan-Pim inhibitor with IC50 of 5/25/16 nM for Pim1/2/3, respectively. |
1353858-99-7 |
DC23036 |
BI-69A11
A potent, selective, ATP competitive AKT inhibitor with IC50 of 2.3 uM for Akt1. |
1233322-09-2 |
DC22651 |
PF-4950834
A potent, selective, ATP-competitive and orally acitve Rho kinase inhibitor with IC50 of 33.1 and 8.5 nM for ROCK1 and ROCK2, respectively. |
1256264-62-6 |
DC23867 |
PF-00337210
A potent, selective, ATP-competitive and orally bioavailable inhibitor of VEGFR-2 with Ki of 0.7 and 8.8 nM for unactivated and fully phosphorylated VEGFR-2, respectively. |
854514-88-8 |
DC11711 |
VER-158411
A potent, selective, ATP-competitive Chk1 and Chk2 inhibitor with IC50 of 4.4 nM and 4.5 nM, respectively. |
1174664-88-0 |
DC11733 |
SAR-020106
A potent, selective, ATP-competitive Chk1 inhibitor with IC50 of 13.3 nM. |
184843-57-9 |
DC12007 |
SOMG-833
A potent, selective, ATP-competitive c-MET inhibitor with IC50 of 0.93 nM. |
1268264-10-3 |
DC23930 |
Bay 65-1942
A potent, selective, ATP-competitive inhibitor of IKKβ kinase with Ki of 2 nM. |
600734-02-9 |
DC22500 |
Bay 65-1942 hydrochloride
A potent, selective, ATP-competitive inhibitor of IKKβ kinase with Ki of 2 nM. |
600734-06-3 |
DC23070 |
MAP4K4-IN-11e
A potent, selective, ATP-competitive inhibitor of MAP4K4 with IC50 of 1.9 uM, without effect on other stress pathway related kinases. |
1774346-60-9 |
DC23964 |
BMS-509744
A potent, selective, ATP-competitive ITK inhibitor with IC50 of 19 nM. |
439575-02-7 |
DC22551 |
DFMTI
A potent, selective, brain penetrant and orally active mGluR1 antagonist with 4.3 nM and 3.6 nM for huam and rat mGluR1, respectively. |
864864-86-8 |
DC22895 |
VU0477573
A potent, selective, brain penetrant partial negative allosteric modulator of mGlu5 receptor with Ki of 14 nM, Ca assay IC50 of 32 nM. |
1946021-40-4 |
DC22964 |
PQ-10
Featured
A potent, selective, brain penetrant PDE10A inhibitor with Ki of 4 nM. |
927691-21-2 |
DC11660 |
PF-4181366
A potent, selective, brain penetrant PDE9A inhibitor with IC50 of 1.8 nM. |
1082743-32-5 |
DC23695 |
PF-05085727
A potent, selective, brain penetrant phosphodiesterase 2A (PDE2A) inhibitor with IC50 of 2 nM, >4,000-fold selectivity over PDE1 and PDE3-11. |
1415637-72-7 |
DC22920 |
AMN 082 dihydrochloride
A potent, selective, brain penetrant, orally acitve mGluR7 allosteric agonist that inhibits forskolin-stimulated cAMP accumulation in mGluR7b CHO cells with EC50 of 64±32 nM. |
97075-46-2 |
DC23640 |
ASP2535
A potent, selective, brain permeable, orally available glycine transporter-1 (GlyT1) inhibitor with IC50 of 92 nM (rat GlyT1), 50-fold selectivity over GlyT2. |
374886-51-8 |
DC11895 |
Foliglurax hydrochloride
A potent, selective, brain-penetrant and orally bioavailable mGluR4 positive allosteric modulator with EC50 of 79 nM. |
2133294-96-7 |
DC11894 |
Foliglurax
A potent, selective, brain-penetrant and orally bioavailable mGluR4 positive allosteric modulator with EC50 of 79 nM. |
1883329-51-8 |
DC20549 |
SHP2 inhibitor 11a-1
A potent, selective, cell active SHP2 inhibitor with IC50 of 200 nM, displays >5-fold selectivity against 20 other mammalian PTPs. |
1620746-09-9 |
DC11948 |
CK2 inhibitor D11
A potent, selective, cell permeab anti-apoptotic protein kinase CK2 with Ki of 5 nM. |
1803427-24-8 |
DC11858 |
BAY-678
Featured
BAY-678 is a cell-permeable inhibitor of human neutrophil elastase (HNE). |
675103-36-3 |
DC22877 |
CPI703
A potent, selective, cell-active CBP/EP300 bromodomain inhibitor with IC50 of 0.47 uM for CBP. |
1904649-00-8 |
DC25052 |
Src I338G-IN-3g
A potent, selective, cell-permeable I338G v-Src inhibitor with IC50 of 430 nM, shows no inhibition of wild-type v-Src at 300 uM. |
206991-94-8 |
DC21474 |
PF-04781340
A potent, selective, CNS penetrant 5-HT2C receptor agonist with Ki of 3 nM and EC50 of 9 nM, without significant P-gp efflux liability. |
1648726-56-0 |
DC22708 |
VU 0255035
A potent, selective, CNS penetrant and competitive orthosteric antagonist of M1 mAChR with IC50 of 132 nM, >75-fold selectivity over M2-M5. |
1135243-19-4 |
DC22667 |
mGlu5 PAM 4k
A potent, selective, CNS penetrant and orally bioavailable mGlu5 positive allosteric modulator that potentiates human mGlu5 with EC50 of 130 nM. |
1382782-16-2 |
DC22684 |
JNJ-46778212
Featured
A potent, selective, CNS penetrant and orally bioavailable mGlu5 positive allosteric modulator that potentiates human mGlu5 with EC50 of 260 nM. |
1363281-27-9 |
DC11558 |
DLK-IN-14
A potent, selective, CNS penetrant dual leucine zipper kinase (DLK, MAP3K12) inhibitor with Ki of 3 nM. |
1620574-24-4 |
DC11870 |
RORγt-IN-9a
A potent, selective, CNS penetrant, orally bioavailable RORγt with pIC50 of 8.3 in FRET assays. |
1426803-07-7 |
DC22730 |
JNJ-42253432
A potent, selective, CNS-penetrant P2X7 antagonist with pKi of 9.1 and 7.9 for rat and huamn P2X7 channel, respectively. |
1428327-35-8 |
DC22903 |
SW-106
Featured
SW106 is a potent, selective, competitive PTH/PTH-related peptide receptor (PPR) antagonist with IC50 of 0.99 uM. |
1027921-53-4 |
DC11898 |
Gosogliptin
A potent, selective, competitive, orally active dipeptidyl peptidase-4 (DPP-4) inhibitor with IC50 of 13 nM. |
869490-23-3 |
DC11899 |
Gosogliptin dihydrochloride
A potent, selective, competitive, orally active dipeptidyl peptidase-4 (DPP-4) inhibitor with IC50 of 13 nM. |
869490-47-1 |
DC23069 |
KRAS G12C inhibitor 1
A potent, selective, covalent KRAS G12C inhibitor that selectively inhibit KRAS G12C-dependent signaling and cancer cell growth at sub-micromolar concentrations.. |
1698023-15-2 |
DC21442 |
ONO 2050297
A potent, selective, dual CysLT1 and CysLT2 antagonist with IC50 of 17 and 0.87 nM, respectively.. |
847655-65-6 |
DC11666 |
BMS-470539
A potent, selective, full agonist of human and murine MC1R with EC50 of 16.8 and 11.6 nM, respectively. |
457893-92-4 |
DC20736 |
AZD 9272
A potent, selective, highly CNS-penetrant and orally available mGluR5 negative allosteric modulator Kd of 2.8 nM. |
327056-26-8 |
DC20723 |
AZD 2066
A potent, selective, highly CNS-penetrant mGluR5 antagonist. |
934282-55-0 |
DC11721 |
PF-06747775
A potent, selective, irreversible EGFR mutants with IC50 of 12, 3, 4 and 5 nM for EGFR L858R-T790M, Del-T790M, L858R, and EGFR Del, respectively. |
1776112-90-3 |
DC22679 |
CM 572
A potent, selective, irreversible sigma-2 receptor partial agonist with Ki of 14.6 nM, >700-fold selectivity over sigma-1 receptors. |
1121932-91-9 |
DC23412 |
BMS-955829
A potent, selective, low glutamate fold shift (2.4) mGluR5 positive allosteric modulator with EC50 of 2.6 nM, without inherent mGluR5 agonist activity (EC50>30 uM). |
1375751-08-8 |
DC22804 |
CMPD-1
A potent, selective, non-ATP-competitive inhibitor of p38α-mediated MK2a phosphorylation with apparent Ki of 330 nM. |
41179-33-3 |
DC22742 |
KAB-18
A potent, selective, noncompetitive human α4β2 nAChRs negative allosteric modulator with IC50 of 13.5 uM, displays no inhibitory activity on Hα3β4 nAChRs at 100 uM.. |
741678-60-4 |
DC23195 |
CBR-5884
Featured
A potent, selective, noncompetitive inhibitor of 3-phosphoglycerate dehydrogenase (PHGDH) with IC50 of 7 uM. |
681159-27-3 |
DC11746 |
JNJ-27141491
A potent, selective, noncompetitive, orally active CCR2 antagonist with IC50 of 172 nM. |
871313-59-6 |
DC22449 |
PD-146176
A potent, selective, non-competitve inhibitor of 15-lipoxygenase (15-LOX) with Ki of 197 nM. |
4079-26-9 |
DC22447 |
FAAH-IN-2
A potent, selective, noncovalent FAAH inhibitor with IC50 of 28 nM toward human FAAH and 100 nM toward rat FAAH. |
1361993-03-4 |
DC11756 |
SR 140333
A potent, selective, non-peptide NK1 receptor antagonist with Ki of 0.74 nM, IC50 of 1.6 nM. |
153050-21-6 |
DC22680 |
Conivaptan
A potent, selective, nonpeptide vasopressin V1A and V2 receptor antagonist with Ki of 0.48 nM and 3.04 nM respectively. |
210101-16-9 |
DC21738 |
TBC3486
A potent, selective, non-peptidic integrin α4β1 (VLA-4) antagonist with IC50 of 9 nM, displays 200-fold selectivity over α4β7 (IC50=2.1 uM). |
247044-77-5 |
DC20617 |
AA-CW236
Featured
A potent, selective, non-pseudosubstrate inhibitor of O(6) -alkylguanine DNA methyltransferase (MGMT) with low-nanomolar potency. |
1869921-96-9 |
DC21593 |
RUC-4
Featured
A potent, selective, non-RGD-mimetic αIIbβ3 integrin receptor antagonist with IC50 of 45 nM, with no activity on αVβ3 receptors. . |
1448313-27-6 |
DC23596 |
Luseogliflozin
A potent, selective, orally acitve SGLT2 inhibitor with IC50 of 2.26 nM, 1650-fold selectivity over SGLT1. |
898537-18-3 |
DC21307 |
MKC-733
A potent, selective, orally active 5-HT3 receptor agonist with high affinity for canine intestinal smooth muscle 5-HT3 receptors. |
194093-42-0 |
DC11667 |
PF-592379
A potent, selective, orally active agonist of dopamine D3 receptor with EC50 of 21 nM. |
710655-15-5 |
DC21606 |
SB-357134
A potent, selective, orally active and CNS penetrant 5-HT6 receptor antagonist with pKi of 8.5, displays 1300-fold selectivity over other 13 5-HT receptor subtypes. |
219963-52-7 |
DC20774 |
VTP 37948
A potent, selective, orally active BACE1 inhibitor for the treatment of Alzheimer's disease.. |
|
DC20665 |
AMG 8718
A potent, selective, orally active BACE1 inhibitor with IC50 of 0.7 nM, demonstrates limited selectivity for over BACE2 and high selectivity both renin and pepsin. |
1215868-94-2 |
DC20324 |
BRS-3 agonist Compound A
A potent, selective, orally active bombesin receptor subtype-3 (BRS-3) agonist with EC50 of 250/100 nM for human/rat BRS-3, resp+H1437+M1438. |
|
DC20325 |
BRS-3 agonist Compound A racemate
A potent, selective, orally active bombesin receptor subtype-3 (BRS-3) agonist with EC50 of 270/130 nM for human/rat BRS-3, respectively. |
|
DC21187 |
JTE907
Featured
A potent, selective, orally active cannabinoid CB2 receptor inverse agonist with Ki of 35.9, 1.55 and 0.38 nM for human, mouse and rat CB2, respectively. |
282089-49-0 |
DC21793 |
VER-250840
A potent, selective, orally active Chk1 inhibitor with IC50 of < 1 nM, Ki=69 pM. |
|
DC22898 |
L-365260
A potent, selective, orally active cholecystokinin receptor 2 (CCK2) antagonist with IC50 of 2 nM. |
118101-09-0 |
DC22485 |
Gefitinib hydrochloride
Featured
A potent, selective, orally active EGFR inhibitor with IC50 of 23 nM. |
184475-55-6 |
DC21443 |
ONO-5334
A potent, selective, orally active inhibitor of cathepsin K with Ki of 0.1 nM, 0.049 nM and 0.85 nM for human, rabbit and rat cathepsin K, respectively. |
868273-90-9 |
DC23340 |
CCT-251455
A potent, selective, orally active monopolar spindle 1 (MPS1) inhibitor with IC50 of 3 nM, with no activity for CDK2 and Aurora A (IC50>40 uM). |
1400284-80-1 |
DC11704 |
CFI-401870
A potent, selective, orally active Mps1 (TTK) inhibitor with IC50 of 3.1 nM. |
1599460-95-3 |
DC25200 |
PF-1355
Featured
PF-1355 is a potent, selective, orally active Myeloperoxidase (MPO) inhibitor with EC50 of 1.47 uM. |
1435467-38-1 |
DC22900 |
MLE-4901
Featured
A potent, selective, orally active neurokinin 3 (NK3R) antagonist for the treatment of schizophrenia. |
941690-55-7 |
DC22664 |
Fezolinetant
Featured
Fezolinetant is an antagonist of the neurokinin 3 receptor (NK3R), used for the treatment of menopausal hot flushes. |
1629229-37-3 |
DC22686 |
SCH 221510
A potent, selective, orally active nociceptin opioid receptor (NOP) agonist with EC50 of 12 nM, Ki of 0.3 nM. |
322473-89-2 |
DC21276 |
Seltorexant
A potent, selective, orally active orexin-2 receptor (OX2R) antagonist with pKi of 8.0 and 8.1 for human and rat OX2R, respectively. |
1293281-49-8 |
DC21148 |
IPI-443
A potent, selective, orally active p110δ/γ PI3K dual inhibitor with cellular IC50 of 0.29 and 7.1 nM, respectively. |
|
DC20681 |
AS1940477
A potent, selective, orally active p38α/p38β inhibitor with IC50 of 11.2/36.5 nM respectively, with no effect on p38γ and δ isoforms (IC50>1 uM). |
928344-12-1 |
DC23441 |
CS-0777
A potent, selective, orally active S1P receptor-1 (S1P1) agonist with EC50 of 1.1 nM, 320-fold selectivity over S1P3. |
827344-05-8 |
DC25065 |
NIBR 0213
Featured
A potent, selective, orally active S1P1 antagonist with IC50 of 2.5 nM Ca2+ mobilization assays, without activity on S1P2, S1P3 and S1P4 (IC50>10 uM). |
1233332-14-3 |
DC21287 |
MK-4256
A potent, selective, orally active somatostatin receptor SSTR3 antagonist with binding Ki of 0.66 nM, >500-fold selectivity over SSTR1/2/4/5. |
1104599-69-0 |
DC21295 |
MK-1421
A potent, selective, orally active somatostatin receptor SSTR3 antagonist with binding Ki of 2.3 nM, >2,500-fold selectivity over SSTR1/2/4/5 (IC50>5 uM). |
1235995-16-0 |
DC21579 |
RO 5073012
A potent, selective, orally active TAAR1 partial agonist with Ki of 6 nM, EC50 of 23 nM (hTAAR1), 140-fold selectivity over β2 adrenergic receptors. |
1020814-70-3 |
DC20654 |
AM-0902
Featured
A potent, selective, orally active TRPA1 channel antagonist with IC50 of 71 and 131 nM for rTRPA1 and hTRPA1 in Ca2+ flux assays respectively, without agonist activity (EC50>40 uM). |
1883711-97-4 |
DC21179 |
JNJ 41876666
A potent, selective, orally active TRPM8 channel antaognist with IC50 of 0.8 nM, . |
1259026-14-6 |
DC11615 |
γ-secretase modulator 14a
A potent, selective, orally active γ-secretase modulator with Aβ42 IC50 of 39 nM. |
1485066-18-9 |
DC23198 |
Adomeglivant
A potent, selective, orally active, small-molecule antagonist of human glucagon receptor with Ki of 6.66 nM. |
1488363-78-5 |
DC22681 |
E 6130
A potent, selective, orally available CX3C chemokine receptor 1 (CX3CR1) modulator that inhibits the fractalkine-induced chemotaxis of human peripheral blood NK cells with IC50 of 4.9 nM. |
1427058-33-0 |
DC23581 |
TASP0315003
A potent, selective, orally available GlyT1 inhibitor with IC50 of 1.6 nM, weakly inhibits rat GlyT2 (IC50=138 nM). |
1007109-16-1 |
DC23611 |
DCCCyB
A potent, selective, orally available GlyT1 inhibitor with IC50 of 29 nM, demonstrates excellent in vivo occupancy of GlyT1 transporters in vivo.. |
1236046-15-3 |
DC23599 |
PF-0346275
Featured
PF-0346275 is a potent, selective, orally available GlyT1 inhibitor with Ki of 11.6 nM, without activity against GlyT2 (IC50>10 uM). |
1173239-39-8 |
DC23486 |
DS-1558
A potent, selective, orally available GPR40 agonist with EC50 of 3.7 nM. |
1202575-67-4 |
DC11683 |
LY2881835
A potent, selective, orally available GPR40 agonist with EC50 of 8 nM. |
1292290-38-0 |
DC11682 |
LY2922083
A potent, selective, orally available GPR40 agonist with EC50 of 9 nM. |
1309435-78-6 |
DC11680 |
LY3104607
A potent, selective, orally available GPR40 agonist with Ki of 15 nM, β-arrestin EC50 of 108 nM. |
1795232-22-2 |
DC23300 |
T-3256336
A potent, selective, orally available IAP antagonist with IC50 of 1.3, 2.2 and 200 nM for cIAP-1, cIAP-2 and XIAP, respectively. |
1266227-69-3 |
DC24182 |
Nilotinib monohydrochloride monohydrate
Featured
A potent, selective, orally available inhibitor of both native and mutant Bcr-Abl with IC50 of 20-80 nM. |
923288-90-8 |
DC23925 |
Vaniprevir
A potent, selective, orally available inhibitor of HCV NS3/4A protease with Ki of 0.05 and 0.9 nM for GT1b and 2a protease, respectively. |
923590-37-8 |
DC11620 |
RIPK2-IN-8
A potent, selective, orally available RIPK2 inhibitor with IC50 of 3 nM. |
2141969-56-2 |
DC11688 |
Avacopan
Featured
Avacopan is a potent, selective, orally availale C5aR (CD88) inhibitor with IC50 of 0.1 nM. |
1346623-17-3 |
DC23358 |
CD 161
A potent, selective, orally bioavailable BET bromodomain inhibitor with IC50 of 7.2 and 28.2 nM for BRD4 BD2 and BRD4 BD1, respectively. |
1627716-22-6 |
DC11623 |
GPR120 agonist 4x
A potent, selective, orally bioavailable GPR120 agonist with EC50 of 42 nM in calcium flux assays. |
1628448-77-0 |
DC21177 |
JNJ 39758979
Featured
JNJ-39758979 is a selective, orally active, and high-affinity histamine H4 receptor antagonist with Kis of 12.5, 5.3, and 25 nM for human, mouse, and monkey histamine H4 receptor, respectively. JNJ-39758979 functionally antagonizes histamine-induced cAMP inhibition with a pA2 of 7.9 in transfected cells. JNJ-39758979 shows good anti-inflammatory and antipruritic activity. |
1046447-90-8 |
DC24048 |
NVP-BKM120 hydrochloride
Featured
A potent, selective, orally bioavailable inhibitor of class I PI3K isoforms with IC50 of 52 nM/166 nM/116 nM/262 nM for p110α/β/δ/γ, respectively. |
1312445-63-8 |
DC22882 |
KRH-3955
A potent, selective, orally bioavailable inhibitor of CXCR4 that efficiently inhibits SDF-1α binding to CXCR4 with IC50 of 0.61 nM. |
1097732-62-1 |
DC24065 |
EPZ-011989 trifluoroacetate
A potent, selective, orally bioavailable inhibitor of EZH2 with Ki of < 3 nM. |
1598383-41-5 |
DC23552 |
AS-2444697 HCl
Featured
A potent, selective, orally bioavailable IRAK-4 inhibitor that potently inhibits human and rat IRAK-4 activity with subnanomolar order, >30-fold selectivity over IRAK-1. |
1287665-60-4 |
DC11835 |
AM-8553
A potent, selective, orally bioavailable MDM2-p53 interaction inhibitor with HTRF IC50 of 1.1 nM, SJSA-1 EdU IC50 of 68 nM. |
1352064-70-0 |
DC11677 |
CCT-271850
A potent, selective, orally bioavailable Mps1 kinase inhibitor with IC50 of 11 nM. |
1578244-34-4 |
DC22941 |
AZD-9056
A potent, selective, orally bioavailable P2X7 receptor antagonist. |
345304-65-6 |
DC11841 |
LAS191954
A potent, selective, orally bioavailable PI3Kδ inhibitor with IC50 of 2.6 nM. |
1403947-26-1 |
DC21607 |
SB-649868
Featured
SB-649868 is a potent and selective orally active orexin (OX) 1 and OX2 receptor antagonist (pKi =9.4 and 9.5 at the OX1 and OX2 receptor, respectively). |
380899-24-1 |
DC21598 |
RWJ-56110
A potent, selective, peptide-mimetic PAR-1 antagonist with binding IC50 of 0.44 uM, with no effect on PAR-2, PAR-3, or PAR-4. |
252889-88-6 |
DC20691 |
ASP 3652
A potent, selective, peripherally active and orally available FAAH inhibitor for treatment of chronic prostatitis/chronic pelvic pain syndrome.. |
|
DC11748 |
LY2033298
Featured
LY2033298 is a robust allosteric potentiator that is highly selective for the human M4 muscarinic acetylcholine receptor subtype. LY2033298 enhances inhibition by oxotremorine of light-induced phase shifts in hamster circadian activity rhythms. |
886047-13-8 |
DC23043 |
Tpl2-IN-2p
A potent, selective, reversible and ATP-competitive inhibitor of Tpl2 kinase with IC50 of 50 nM. |
871307-18-5 |
DC23933 |
MK-0893
A potent, selective, reversible and competitive antagonist of glucagon receptor with high binding affinity (IC(=50=6.6 nM) and functional cAMP activity (IC50=15.7 nM). |
870823-12-4 |
DC11691 |
NSC95397
Featured
A potent, selective, reversible Cdc25 dual specificity phosphatase inhibitor with Ki of 32/96/40 nM for Cdc25A/B/C, respectively. |
93718-83-3 |
DC11978 |
SB 265610
Featured
SB-265610 is a selective, competitive, nonpeptide and allosteric CXCR2 antagonist. |
211096-49-0 |